The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence
Gene expression-based prediction of genomic copy number aberrations in the chromosomal region 12q13 to 12q15 that is flanked by MDM2 and CDK4 identified Wnt inhibitory factor 1 (WIF1) as a candidate tumor suppressor gene in glioblastoma. WIF1 encodes a secreted Wnt antagonist and was strongly downregulated in most glioblastomas as compared with normal brain, implying deregulation of Wnt signaling, which is associated with cancer. WIF1 silencing was mediated by deletion (7/69, 10%) or epigenetic silencing by promoter hypermethylation (29/110, 26%). Co-amplification of MDM2 and CDK4 that is present in 10% of glioblastomas was associated in most cases with deletion of the whole genomic region enclosed, including the WIF1 locus. This interesting pathogenetic constellation targets the RB and p53 tumor suppressor pathways in tandem, while simultaneously activating oncogenic Wnt signaling.
Keywords: epigenetic silencing ; glioblastoma ; senescence ; tumor suppressor gene ; Wif1 ; Wnt pathway ; Newly-Diagnosed Glioblastoma ; Colorectal-Cancer Cells ; Promoter Methylation ; Adjuvant Temozolomide ; Signaling Pathway ; Factor-I ; Epigenetic Inactivation ; Down-Regulation ; Beta-Catenin ; Expression
Record created on 2011-12-16, modified on 2016-08-09